title: Plantar exfoliation and desquamation during efalizumab therapy.
authors.forename: E
authors.initials: E
authors.lastname: Adíşen
authors.forename: M A
authors.initials: MA
authors.lastname: Gürer
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D005528:Foot / Q000473:pathology; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab